IMPACT: Publications

2026

Prognostic Factors for Overall Survival in the VESPER Trial: Basal Molecular Subtype Is a Relevant Key Factor

Pfister C, Harter V, Fontugne J, Allory Y, Culine S; VESPER Trial Investigators

Eur Urol Oncol. S2588-9311(26)00004-0, 2026.

Tobacco’s dual genomic footprints in bladder cancer revealed by multi-omics analysis: An SBS4-like LumU-enriched signature and smoking-driven HRD-related genomic instability

Meng XY, Shi MJ, Li S, Liu M, Fontugne J, Song J, Radvanyi F, Wang FB, Bernard-Pierrot I, Wang XH

Accepted in Genes and Diseases, 2026.

Consulter sur ScienceDirect